— Know what they know.
Not Investment Advice

PG vs CL vs EL

161 measures in 16 categories, one definition each, computed from filings and market data.
PG64.1
The Procter & Gamble Company
Consumer Defensive · Household & Personal Products
$159.31 +1.45%$370.0B mkt cap
Score DNA
CL60.5
Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
$94.11 +1.52%$75.0B mkt cap
Score DNA
EL53.7
The Estée Lauder Companies Inc.
Consumer Defensive · Household & Personal Products
$104.54 −2.48%$37.9B mkt cap
Score DNA

Price, rebased to 100 three years ago

PG   CL   EL   · weekly adjusted closes
406080100120140160Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26CL 140PG 119EL 79
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasurePGCLEL
Insider open-market buys, 180d 0 0 0
Insider $ bought, 180d — — —
Congress purchases, 180d 16 1 5
Last Congress purchase 2026-09-25 2026-06-02 2026-07-02
13F net change in holders +20 +67 0
ETFs adding shares, 30d 1,512 1,229 1,149
ETFs trimming, 30d 1,258 971 833
Net ETF funds, 30d +254 +258 +316

Valuation

16 measures
MeasurePGCLEL
P/E (TTM) 23.1x
55th
36.8x
73rd
208.1x
100th
PEG (P/E ÷ 3-yr EPS CAGR) 5.99
100th
3.08
71st
—
Price / sales 4.3x
100th
3.6x
84th
2.5x
74th
Price / book 6.8x
79th
317.9x
100th
10.0x
84th
Price / tangible book — — —
Price / free cash flow 23.3x
75th
19.4x
56th
28.8x
100th
Price / operating cash flow 18.2x
81st
16.8x
69th
21.4x
94th
Enterprise value $395.1B
100th
$81.5B
95th
$43.6B
84th
EV / sales 4.5x
100th
3.9x
84th
2.9x
79th
EV / EBITDA 16.2x
44th
21.2x
69th
26.5x
75th
EV / EBIT 18.6x
43rd
25.5x
50th
51.3x
79th
EV / free cash flow 24.8x
69th
21.1x
56th
33.1x
81st
Earnings yield 4.3%
68th
2.7%
58th
0.5%
42nd
FCF yield 4.3%
37th
5.1%
53rd
3.5%
16th
Operating cash flow yield 5.5%
32nd
5.9%
42nd
4.7%
21st
Graham number (per share) $57.80
91st
$4.08
0th
$10.87
36th

Profitability (TTM)

12 measures
MeasurePGCLEL
Gross margin 50.2%
53rd
60.4%
68th
75.5%
100th
EBITDA margin 28.1%
100th
18.2%
74th
10.9%
47th
Operating margin 22.7%
95th
20.7%
89th
11.1%
58th
EBIT margin 24.4%
100th
15.2%
79th
5.7%
47th
Net margin 18.4%
100th
9.7%
74th
1.2%
42nd
NOPAT margin 18.0%
95th
15.2%
89th
3.9%
32nd
FCF margin 18.3%
95th
18.3%
100th
8.7%
53rd
Operating cash flow margin 23.4%
100th
21.2%
95th
11.8%
53rd
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 27.5%
26th
39.3%
63rd
64.4%
84th
Stock comp / revenue 0.6%
33rd
0.5%
28th
2.1%
83rd
Effective tax rate 20.8%
5th
26.5%
79th
64.8%
100th

Returns on capital

11 measures
MeasurePGCLEL
ROE (on average equity) 30.2%
84th
434.3%
100th
4.7%
47th
ROA 12.7%
100th
11.9%
95th
0.9%
42nd
ROIC 19.7%
68th
47.5%
89th
6.2%
37th
ROCE 24.2%
95th
30.0%
100th
6.3%
53rd
Return on tangible assets 16.9%
89th
18.7%
100th
4.3%
47th
Cash ROIC (OCF / invested capital) 25.6%
76th
66.3%
94th
18.6%
65th
Gross profitability (GP / assets) 34.5%
47th
75.7%
100th
57.5%
79th
ROIC, 3-yr average 17.4%
82nd
35.0%
100th
1.2%
29th
ROIC, 5-yr average 20.6%
93rd
— 6.4%
43rd
ROE, 5-yr average 30.6%
88th
— 8.7%
50th
Incremental ROIC 160.6%
95th
-77.2%
42nd
-392.5%
5th

Growth

17 measures
MeasurePGCLEL
Revenue growth (TTM YoY) 3.3%
68th
5.2%
79th
5.1%
74th
Revenue growth (QoQ) -0.2%
21st
0.7%
32nd
-2.3%
5th
Revenue CAGR, 3 yr 2.0%
56th
4.1%
67th
-1.8%
28th
Revenue CAGR, 5 yr 2.7%
53rd
4.3%
60th
-1.5%
33rd
Gross profit CAGR, 3 yr 3.6%
39th
6.2%
56th
0.0%
28th
Operating income CAGR, 3 yr 2.9%
33rd
4.2%
58th
3.6%
42nd
Net income growth (TTM YoY) 0.5%
50th
-30.0%
20th
—
Net income CAGR, 3 yr 3.1%
30th
10.8%
60th
-43.4%
10th
EPS growth (TTM YoY) 1.8%
50th
-29.0%
20th
—
EPS CAGR, 3 yr 3.8%
30th
12.0%
60th
-43.7%
10th
EPS CAGR, 5 yr 3.6%
78th
-4.7%
11th
-42.2%
0th
FCF growth (TTM YoY) 13.3%
15th
14.5%
23rd
96.4%
85th
FCF CAGR, 3 yr 4.9%
46th
17.9%
69th
—
Operating cash flow CAGR, 3 yr 6.4%
57th
12.9%
64th
0.8%
36th
Book value CAGR, 3 yr 5.9%
65th
— -12.4%
24th
Dividend CAGR, 3 yr 2.0%
92nd
1.4%
67th
-6.7%
8th
Sustainable growth rate 10.9%
73rd
45.8%
100th
-8.5%
0th

Margin history & stability

7 measures
MeasurePGCLEL
Gross margin, 3-yr average 50.9%
53rd
60.2%
74th
73.7%
100th
Operating margin, 3-yr average 23.0%
100th
21.7%
95th
4.9%
32nd
Net margin, 3-yr average 18.4%
100th
12.8%
95th
-1.4%
37th
FCF margin, 3-yr average 18.7%
100th
17.3%
95th
7.6%
53rd
Revenue stability (0-1) 0.95
79th
0.97
95th
0.67
37th
Earnings stability (0-1) 0.85
89th
0.01
5th
0.79
84th
Margin stability (0-1) 0.97
74th
0.97
79th
0.97
68th

Liquidity (latest quarter)

7 measures
MeasurePGCLEL
Cash & short-term investments $9.9B
100th
$1.4B
89th
$3.5B
95th
Net cash (− = net debt) −$25.1B
0th
−$6.5B
11th
−$5.7B
16th
Working capital −$12.5B
0th
$160.0M
42nd
$1.4B
100th
Current ratio 0.68
5th
1.03
26th
1.22
42nd
Quick ratio 0.47
11th
0.67
21st
0.90
53rd
Cash ratio (cash + ST investments / current liabilities) 0.26
47th
0.22
42nd
0.56
63rd
Defensive interval (days) 244 days
42nd
145 days
5th
189 days
32nd

Leverage & solvency (latest quarter)

13 measures
MeasurePGCLEL
Total debt $35.0B
100th
$7.9B
84th
$9.2B
95th
Debt / equity 0.64
32nd
33.29
95th
2.43
84th
Net debt / equity 0.46
26th
27.49
95th
1.51
74th
Debt / assets 27.7%
32nd
46.8%
79th
46.8%
74th
Debt / capital 39.2%
32nd
97.1%
95th
70.8%
84th
Debt / EBITDA 1.43
6th
2.05
19th
5.61
62nd
Net debt / EBITDA 1.03
6th
1.69
19th
3.49
56th
Interest coverage (EBIT / interest) 24.2x
94th
12.5x
83rd
2.5x
44th
Cash interest coverage 23.2x
89th
17.5x
83rd
5.3x
44th
Debt payback (years of OCF) 1.7 yrs
12th
1.8 yrs
19th
5.2 yrs
69th
Liabilities / assets 57.1%
42nd
96.6%
95th
80.7%
84th
IS credit model rating AA A+ BB
Implied credit spread (bps) 80
5th
125
16th
475
58th

Efficiency

11 measures
MeasurePGCLEL
Asset turnover 0.69
26th
1.23
95th
0.76
37th
Fixed asset turnover 3.43
17th
4.54
39th
3.04
11th
Inventory turnover 5.5
68th
3.9
58th
1.8
11th
Receivables turnover 14.2
79th
11.3
74th
9.9
47th
Days sales outstanding 26 days
21st
32 days
26th
37 days
53rd
Days inventory outstanding 66 days
32nd
94 days
42nd
202 days
89th
Days payables outstanding 133 days
84th
86 days
58th
152 days
95th
Cash conversion cycle (days) −41 days
5th
41 days
32nd
86 days
58th
Capex / revenue 5.1%
100th
2.8%
53rd
3.0%
65th
Capex / depreciation 1.40
100th
0.93
76th
0.57
41st
Operating expense ratio 29.9%
28th
42.5%
56th
68.5%
83rd

Cash flow & earnings quality

7 measures
MeasurePGCLEL
Operating cash flow / net income 1.27
18th
2.19
73rd
9.74
100th
FCF / net income 0.99
27th
1.89
73rd
7.23
100th
FCF / operating cash flow 78.3%
56th
86.6%
62nd
74.2%
38th
Capex / operating cash flow 21.7%
44th
13.4%
38th
25.8%
62nd
Accruals ratio -3.4%
79th
-14.1%
5th
-8.0%
26th
Sloan accruals ratio -4.0%
42nd
1.7%
84th
-5.3%
26th
Earnings quality score (0-1) 1.00
73rd
0.75
9th
0.75
9th

Dividends & buybacks

9 measures
MeasurePGCLEL
Dividend yield 2.7%
68th
2.2%
58th
1.3%
47th
Dividend per share (TTM) $4.32
89th
$2.10
79th
$1.40
68th
Payout ratio (dividends / net income) 63.8%
64th
89.4%
82nd
279.1%
100th
Dividends / FCF 64.3%
81st
47.2%
62nd
38.6%
50th
Dividend growth (YoY) 5.0%
92nd
2.4%
69th
-18.3%
15th
Buyback yield 1.4%
58th
0.6%
47th
0.4%
37th
Shareholder yield (dividends + buybacks) 4.1%
63rd
3.1%
32nd
1.7%
26th
Share count change (YoY) -1.3%
32nd
-1.3%
21st
0.7%
58th
Buybacks, last 5 years $27.8B
100th
$3.0B
89th
$247.0M
63rd

Scores & forensic checks

15 measures
MeasurePGCLEL
IS score 64
89th
61
79th
54
58th
IS profitability 70
95th
72
100th
29
37th
IS growth 44
37th
49
53rd
60
89th
IS value 48
53rd
39
26th
36
11th
IS momentum 72
63rd
58
47th
88
100th
IS risk (safety) 100
84th
100
84th
65
47th
IS quality 79
89th
64
63rd
55
53rd
IS balance sheet 63
89th
46
53rd
37
37th
IS earnings quality 86
100th
62
42nd
74
74th
IS cash flow 67
63rd
72
84th
64
58th
Piotroski F-score (0-9) 6
53rd
8
79th
7
63rd
Altman Z-score 5.6
89th
6.9
95th
2.9
53rd
Beneish M-score −2.67
79th
−3.14
16th
−2.90
37th
Ohlson O-score −8.85
11th
−5.71
79th
−6.88
47th
IS credit score 86
95th
77
84th
44
42nd

Per share

7 measures
MeasurePGCLEL
EPS, diluted (TTM) $6.62
100th
$2.53
68th
$0.50
47th
Book value per share $22.42
74th
$0.29
0th
$10.48
53rd
Tangible book per share −$3.47
47th
−$5.06
26th
−$5.18
21st
Revenue per share $35.93
58th
$26.12
42nd
$41.45
63rd
FCF per share $6.57
84th
$4.79
74th
$3.62
58th
Operating cash flow per share $8.39
89th
$5.53
74th
$4.88
53rd
Cash per share $4.10
58th
$1.70
42nd
$9.63
95th

Size (TTM)

8 measures
MeasurePGCLEL
Market cap $370.0B
100th
$75.0B
95th
$37.9B
89th
Revenue $87.0B
100th
$21.0B
95th
$15.0B
79th
EBITDA $24.4B
100th
$3.8B
95th
$1.6B
79th
Net income $16.0B
100th
$2.0B
95th
$182.0M
63rd
Free cash flow $15.9B
100th
$3.9B
95th
$1.3B
79th
Total assets $126.5B
100th
$16.8B
79th
$19.8B
89th
Shareholders' equity $54.3B
100th
$236.0M
21st
$3.8B
84th
Employees 104,000
100th
33,600
84th
41,800
95th

Price performance

9 measures
MeasurePGCLEL
1 day +1.4% +1.5% −2.5%
1 week +5.4% +6.6% +6.6%
1 month +8.0% +7.2% +11.4%
3 months +7.7% +2.3% +25.0%
6 months +10.1% +10.3% +37.2%
Year to date +14.9% +21.8% −1.8%
1 year +11.3% +22.0% +10.1%
3 years, cumulative +20.6% +43.9% −22.2%
5 years, cumulative +27.8% +37.8% −64.2%

Technicals

4 measures
MeasurePGCLEL
RSI 14 75.2 73.1 63.8
From 52-week high −3.3% −5.3% −13.8%
From 52-week low +18.4% +26.2% +57.9%
Beta 0.38 0.32 1.27
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms